Application of polypyrimidine sequence binding protein in preparation of drugs for repairing spinal cord injury
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- NANTONG UNIVERSITY
- Publication Date
- 2021-07-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and specifically relates to the application of a polypyrimidine sequence-binding protein silencing agent in combination with retinoic acid and purmorphamine in the preparation of spinal cord injury repairing medicine. Background technique
[0002] Spinal cord injury (SCI) is a central nervous system injury disease with high disability rate and serious consequences, which seriously impairs the motor function of patients and often leads to paralysis below the injury site. Currently recognized SCI treatment has three major difficulties: First, rapidly activated reactive glial cells, especially astrocytes, will proliferate in large numbers to form dense glial scar tissue, allowing relatively slow-growing axons to extend through the injury When in the process of living, it encounters an insurmountable mechanical barrier and a chemical barrier formed by the secreted inhibitory factors; second, some...